Skip to main content
U.S. flag

An official website of the United States government

NIH OAR Data Hub: NIH HIV and Aging Topical Portfolio Analysis

Need help? Click here for video tutorials, definitions, and other resources to help navigate the Data Hub. Email OARinfo@nih.gov with any feedback.

The NIH OAR Data Hub leverages and synthesizes publicly available data about the NIH HIV research portfolio to promote greater understanding of this research and to enable researchers to identify awards relevant to their specific interests.

The dashboard below is a comprehensive review of the research portfolio at the intersection of HIV and Aging. There are two sheets on the dashboard. Use the “Topical Portfolio Analysis” sheet to explore the two-way intersection of NIH awards for HIV and Aging research and the three-way intersection of HIV, Aging, and a NIH spending category of interest by year, funding Institute, Center or Office (funding ICO), and activity. Use the “Category Comparison” sheet to explore two three-way intersections between HIV, Aging, and an additional NIH spending category of interest.

 

Caption: The “NIH HIV and Aging Topical Portfolio Analysis” contains two sheets that allow users to explore the intersections of HIV and Aging related awards. The top of the dashboard contains sheets to view the different HIV and Aging related dashboards. The “Topical Portfolio Analysis” sheet displays the number of awards and the intersect funding at the two-way intersection of HIV and Aging and the three-way intersection of HIV, Aging and a third NIH spending category by fiscal year, funding Institute, Center, and Office (funding ICO) and activity. The view can be filtered by fiscal year, funding ICO and activity.

The “Category Comparison” sheet displays the number of awards and intersect funding between two three-way intersections between HIV, Aging, and an additional NIH spending category of interest. The view can be filtered by fiscal year, funding ICO and activity code.

This page last reviewed on July 22, 2024